NNovo Nordisk Read More Novo Nordisk’s Wegovy: Pioneering Weight Loss Innovation2026-08-19 Novo Nordisk, the Danish pharmaceutical giant, is intensifying its pursuit of weight-loss innovation with a new late-stage study…
NNovo Nordisk Read More H1 and Novo Nordisk Partner to Advance AI-Driven Clinical Development2026-08-05 What You Should Know Healthcare data and AI platform H1 announced a strategic partnership with global pharmaceutical leader…
NNovo Nordisk Read More Novo Nordisk Sues Eli Lilly Over Misleading Weight-Loss Drug Ads2026-07-21 Novo Nordisk has taken legal action against Eli Lilly, filing a lawsuit in a U.S. federal court alleging…
NNovo Nordisk Read More Novo Nordisk flags patient data breach from some clinical trials in cyberattack2026-06-19 June 11 (Reuters) – Novo Nordisk said on Thursday it has identified a security incident in which certain…
NNovo Nordisk Read More Novo Nordisk identifies unauthorised data access from trials2026-06-12 Novo Nordisk has identified that certain patient information from some of its clinical trials was accessed and copied…
NNovo Nordisk Read More Novo Nordisk identifies unauthorised data access from trials2026-06-12 Novo Nordisk has identified that certain patient information from some of its clinical trials was accessed and copied…
NNovo Nordisk Read More Novo Nordisk flags IT security incident2026-06-11 !- – Start GPT Tag – -> <!- – End GPT Tag – -> …
NNovo Nordisk Read More Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior2026-05-11 Micha Breakstone, Ph.D., peers into a microscope. [Cellular Intelligence] Cellular Intelligence has acquired global rights to a clinical-stage…
NNovo Nordisk Read More Race for AI-developed drugs heats up: Wegovy-maker Novo Nordisk ties up with OpenAI after rival Eli Lilly seals deal2026-04-14 Danish drugmaker Novo Nordisk on Tuesday announced that it is collaborating with ChatGPT’s parent company, OpenAI, to bring…
NNovo Nordisk Read More Eli Lilly Gets Speedy FDA Nod for Oral GLP-1 Drug, a Competitor to New Novo Nordisk Pill2026-04-01 Eli Lilly now has FDA approval for its GLP-1 obesity pill, introducing a convenient dosing alternative to injections…
AAmsterdam Read More PharmAla To Supply Amsterdam UMC with LaNeo™ MDMA,2026-02-23 TORONTO, Feb. 23, 2026 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused…